Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MMED · against 224 other Healthcare companies of similar size
Ranked #167 of 225 · scores higher than 25% of peers
Bars: peers in each 10-point band of the profitability score8 peers with a profitability score of 30–39, including MMED · Click a bar to see the companies
Mainly because of its return on assets, operating margin and return on invested capital, which are weaker than most Healthcare peers.
| Metric | MMED | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 217 reported | -4.0% | 8.2% | 25% | 33% | |
| Operating marginHigher is better · 205 reported | -5.3% | 10.9% | 19% | 33% | |
| Return on assetsHigher is better · 215 reported | -6.7% | 3.2% | 25% | 33% | |
| Return on equityHigher is better · 210 reported | -8.7% | 7.5% | 29% | Context only | |
| Gross marginHigher is better · 233 reported | 56.9% | 49.5% | 62% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 3 | 3.8B USD | 99 | 71 | |
| 3 | 2.7B USD | 99 | 84 | |
| 164 | 20.7B CNY (≈$2.9B) | 37 | 51 | |
| 165 | 8.6B USD | 36 | 30 | |
| 166 | 4.7B USD | 34 | 42 | |
| 167 | 24.9B CNY (≈$3.5B) | 31 | 38 | |
| 167 | 5.3B USD | 31 | 50 | |
| 169 | 2.8B USD | 30 | 33 | |
| 170 | 31.0B CNY (≈$4.3B) | 29 | 26 | |
| 170 | 2.9B USD | 29 | 44 | |
| 172 | 6.0B USD | 28 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score